UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted ...

A surgeon in London has carried out what is being described as the United Kingdom’s first long-distance robotic operation on ...

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

In a medical achievement that highlights how technology is reshaping modern healthcare, a surgeon in London has successfully carried out a complex cancer operation on a patient located roughly 1,500 ...

FV Hospital aims to develop into a leading robotic surgery hub in Southeast Asia, with the long-term goal of making the world ...

Profound Medical (PROF) announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic ...

Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.

The remarkable story of the London surgeon who has carried out the UK’s first remotely controlled prostate operation - operating on a patient 1,500 miles away in Gibraltar.

Hundreds of cancer patients in the region are to benefit from a new surgical robot thanks to a £1.45m donation from Sheffield Hospitals Charity, the largest ever single donation from the charity.

PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation platform for delivering Aquablation therapy to treat benign ...

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...